The Oncology Institute, Inc. Common Stock
TOIStock
$5.26+95.64%52W
Market Cap$567.40M
P/E—
Div yield—
Beta0.35
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)43.38%
Price vs S&P 500 (4W)21.63%
VGM Score68.84
Market Capitalization$567.40M
Earnings Surprise History
Q1 26-0.02est. -0.08
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.13
4.13
4.13
4.13
Industry Peers — Physicians' Offices(10)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TOIThe Oncology Institute, Inc. Common Stock | D | A | A | $5.26 |
| HIMSHims & Hers Health, Inc. | F | C | B | $33.68 |
| TDOCTeladoc Health, Inc. | B | C | B | $9.47 |
| SBCSBC Medical Group Holdings Incorporated Common Stock | B | F | D | $3.17 |
| AIRSAirSculpt Technologies, Inc. Common Stock | D | D | B | $4.16 |
| LFMDLifeMD, Inc. Common Stock | D | C | D | $4.50 |
| AUNAAuna S.A. | A | D | D | $5.15 |
| BMGLBasel Medical Group Ltd Ordinary Shares | B | B | C | $5.60 |
| CCMConcord Medical Services Holding Limited | B | B | C | $4.35 |
| SBCWWSBC Medical Group Holdings Incorporated Warrants | — | — | C | $0.30 |
| TOIIWThe Oncology Institute, Inc. Warrant | — | — | C | $0.07 |
About
The Oncology Institute Inc operates a diversified oncology platform providing infusion services, specialty pharmacy dispensing, stem cell transplants, clinical trials, and supportive care services. The company generates revenue primarily through its patient services segment, with additional contributions from its proprietary dispensary and clinical trials operations. Its integrated model spans diagnosis, treatment, research, and comprehensive patient support across the oncology care continuum.